Company profile
Destina Genomics Ltd
DESTINA Nucleic Acid Testing
Destina Genomics Ltd is a UK company with status active founded in 2010 based in Scotland.
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQzMTUwOTgyM2FkaXF6a2N4
Published 07 Aug 2024 14:12
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Feasibility of a rapid, sensitive, nucleic acid based test for detection and serotyping of enteric viruses of human health importance
1 Dec 2012 to 30 Nov 2013
This project will evaluate the feasibility of a rapid, specific and cheap test for human entric viruses. We will apply our novel patented technology that is able to detect and distinguish specific DNA/RNA sequences as the basis for the test. This will enable viral detection and serotyping, and we suggest that our assay would overcome many of the limitatio...
Detection of bovine mastitis pathogens using novel nucleic acid testing technology
1 Aug 2012 to 30 Nov 2012
The objective of this study is the development of a rapid and cheap multiplexed assay to screen milk prior to processing. This will facilitate the identification of contaminated milk, infected herds and individual animals. The project is innovative in that it will apply novel chemical based nucleic acid detection technology to the identification of bacter...
Novel nucleic acid detection for determining norovirus levels in food
1 May 2011 to 31 Jul 2011
Awaiting Public Summary
Novel companion biomarker assay for glioma cancer drug development to overcome current lack of in-vitro test success
1 May 2011 to 31 Jul 2011
Awaiting Public Summary